Learn more about AbbVie, its focus areas for drug discovery and development, its partnering interests, and its commitment to the west coast innovation ecosystem. RSVP Scott Brun, MD, is AbbVie’s Vice President, Chief Strategy Office and Head of AbbVie Ventures, where he works closely with the Chief Strategy Officer and executive management team to identify and execute on strategic venture investments that are closely aligned with AbbVie’s overall R&D and corporate strategy. Scott also serves as AbbVie's Vice President, Scientific Affairs. Prior to this role, Scott led Pharmaceutical Development at AbbVie and was responsible for advancing a broad pipeline across several therapeutic areas. In his 20+ year career at Abbott/AbbVie, he held roles of increasing responsibility across the research and development organization. Scott earned his bachelor’s degree in biochemistry from the University of Illinois at Urbana-Champaign. He earned his medical degree from The Johns Hopkins University School of Medicine and completed ophthalmology training at the Massachusetts Eye and Ear Infirmary/Harvard Medical School. Steve Davidsen, PhD, is Vice President, Discovery Oncology in AbbVie’s R&D organization, where he is responsible for discovery and research efforts of AbbVie’s Oncology programs. Prior to AbbVie’s separation from Abbott, Dr. Davidsen served as Divisional Vice President, […]